Nonorganic hypersomnia - Epidemiology, diagnosis and treatment;Nichtorganische hypersomnie - Epidemiologie, diagnose und therapie

Wiener Klinische Wochenschrift

Volumn 113, Issue 7-8, 2001, Pages 266-277

  Saletu, B ^a   Anderer, P ^a   Saletu Zyhlarz, G M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Diagnostic procedures; Epidemiology; Nonorganic hypersomnia; Psychiatric causes; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BRONCHODILATING AGENT; CARDIAC AGENT; CENTRAL STIMULANT AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC AGENT; MELATONIN; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ANAMNESIS; AUSTRIA; CHRONIC FATIGUE SYNDROME; CLINICAL EXAMINATION; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELECTROCONVULSIVE THERAPY; HUMAN; HYDROTHERAPY; HYPERSOMNIA; LASER SURGERY; MENTAL DISEASE; OSTEOTOMY; PATHOGENESIS; POLYSOMNOGRAPHY; PREVALENCE; PSYCHOTHERAPY; REVIEW; SOMNOLENCE;

EID: 0035901545     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Zur epidemiologie von schlafstörungen in Österreich
2. The epidemiology of fatigue: More questions than answers
3. Klinik von schlafstörungen - Erfahrungen über 817 patienten einer schlafambulanz
4. Comorbidity of nonorganic and organic sleep disorders
5. Sleeping habits in the Austrian population
6. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research
7. Six-month prevalence of psychiatric disorder in three communities
8. Lifetime prevalence of specific psychiatric disorders in three sites
9. Psychiatric disorders in general practice attenders with chronic fatigue syndrome
10. Fatigue in primary care: Prevalence, psychiatric comorbidity, illness behavior, and outcome
11. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples
12. Schlafstörungen aus psychiatrischer sicht - Der effiziente weg zur diagnose und therapie
13. Visualizing the living human brain. The techniques and promise of EEG and event-related potentials mapping
14. Pharmacodynamics and EEG. I. From single-lead pharmaco-EEG to EEG mapping
15. Schlafstörungen
16. Erste klinische Erfahrungen mit einem neuen schlafanstoßenden Benzodiazepin, Cinolazepam, mittels eines Selbstbeurteilungsbogens für Schlaf- Und Aufwachqualität (SSA)
17. Schlaffragebogen A und B
18. The sleep disorder questionnaire. I. Creation and multivariate structure of the SDQ
19. Bedeutung eines screeening-fragebogens zur diagnostik von schlafapnoe
20. New techniques for the analysis of the human sleep-wake cycle
21. Eine neue methode zur messung der zentralen aktivierung: Fourieranalyse der pupillenoszillationen bei depressiven patienten
22. Pupillographic assessment of sleepiness in sleep-deprived healthy subjects
23. Vigilance performance and automatic function in narcolepsy: Effects of central stimulants
24. Auditory evoked potentials compared to EEG and performance measures of impaired vigilance in narcolepsy-cataplexy
25. Topographic brain mapping of EEG in neuropsychopharmacology - Part I. Methodological aspects
26. Topographic brain mapping of EEG in neuropsychopharmacology - Part II. Clinical applications (Pharmaco EEG imaging)
27. Psychodiagnostische erfassung von schlafstörungen
28. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
29. The development and use of the Stanford sleepiness scale (SSS)
30. Visuelle analogskalen zur erfassung von schlafqualität (VIS-A und VIS-M) Selbstbeurteilungsskala (S)
31. Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
32. Der multiple Einschlaflatenz-Test (MSLT) in der differentialdiagnose der narkolepsie
33. Maintenance of wakefulness test: A polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence
34. An alternative to the multiple sleep latency test for determining sleepiness in narcolepsy and hypersomnia: Polygraphic score of sleepiness
35. Der Benton Test
36. Die Befindlichkeitsskala (B-S) - Ein einfaches instrument zur objektivierung von befindlichkeitsstörungen, insbesondere im rahmen von längsschnittuntersuchungen
37. Die Beschwerden-Liste als Test
38. CFF and assessment of pharmacodynamics: Role and relationship to psychometric, EEG and pharmacokinetic variables
39. Klinische psychodiagnostik mit hilfe psychophysiologischer verfahren
40. A rating scale for depression
41. A self-rating depression scale
42. The assessment of anxiety states by rating
43. A rating instrument for anxiety disorders
44. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician
45. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (Adrafinil) in elderlies
46. On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: Double-blind placebo-controlled clinical, psychometric and neurophysiological studies
47. Treatment of the alcoholic organic brain syndrome: Double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil
48. Pathophysiological and clinical aspects of narcolepsy: A disorder associated with hypocretin abnormalities
49. Hypothalamic arousal regions are activated during modafinil-induced wakefulness
50. Differential effects of a new central adrenergic agonist - modafinil - and d-amphetamine on sleep and early morning behaviour in young healthy volunteers
51. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies
52. Zur wirkung eines neuen zentralen alpha-adrenergen agonisten modafinil auf die schlaf- und aufwachqualität: vergleichende schlaflaboruntersuchung mit d-amphetamin bei jugendlichen und geriatrischen probanden
53. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy